nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—LTK—tongue—cleft lip	0.0168	0.0554	CbGeAlD
Ruxolitinib—LTK—mouth—cleft lip	0.0113	0.0373	CbGeAlD
Ruxolitinib—ANKK1—telencephalon—cleft lip	0.0109	0.0361	CbGeAlD
Ruxolitinib—RPS6KA6—embryo—cleft lip	0.00999	0.033	CbGeAlD
Ruxolitinib—GRK1—telencephalon—cleft lip	0.00864	0.0285	CbGeAlD
Ruxolitinib—PRKCE—telencephalon—cleft lip	0.00846	0.0279	CbGeAlD
Ruxolitinib—PLK3—embryo—cleft lip	0.00834	0.0275	CbGeAlD
Ruxolitinib—GRK7—head—cleft lip	0.00744	0.0246	CbGeAlD
Ruxolitinib—ANKK1—head—cleft lip	0.00681	0.0225	CbGeAlD
Ruxolitinib—JAK1—embryo—cleft lip	0.0064	0.0211	CbGeAlD
Ruxolitinib—DCLK1—embryo—cleft lip	0.0064	0.0211	CbGeAlD
Ruxolitinib—CAMK1—telencephalon—cleft lip	0.00634	0.0209	CbGeAlD
Ruxolitinib—PRKG2—head—cleft lip	0.00564	0.0186	CbGeAlD
Ruxolitinib—ROCK1—embryo—cleft lip	0.00551	0.0182	CbGeAlD
Ruxolitinib—GRK1—head—cleft lip	0.00538	0.0178	CbGeAlD
Ruxolitinib—PRKCE—head—cleft lip	0.00527	0.0174	CbGeAlD
Ruxolitinib—JAK1—telencephalon—cleft lip	0.0052	0.0172	CbGeAlD
Ruxolitinib—DCLK1—telencephalon—cleft lip	0.0052	0.0172	CbGeAlD
Ruxolitinib—PLK1—head—cleft lip	0.00506	0.0167	CbGeAlD
Ruxolitinib—RPS6KA6—head—cleft lip	0.00506	0.0167	CbGeAlD
Ruxolitinib—MAST1—head—cleft lip	0.00506	0.0167	CbGeAlD
Ruxolitinib—DAPK2—telencephalon—cleft lip	0.00496	0.0164	CbGeAlD
Ruxolitinib—HIPK2—telencephalon—cleft lip	0.00486	0.016	CbGeAlD
Ruxolitinib—DCLK3—head—cleft lip	0.0048	0.0158	CbGeAlD
Ruxolitinib—DAPK3—telencephalon—cleft lip	0.00467	0.0154	CbGeAlD
Ruxolitinib—ROCK1—telencephalon—cleft lip	0.00448	0.0148	CbGeAlD
Ruxolitinib—DYRK1A—telencephalon—cleft lip	0.00437	0.0144	CbGeAlD
Ruxolitinib—BMPR2—telencephalon—cleft lip	0.00435	0.0144	CbGeAlD
Ruxolitinib—PLK3—head—cleft lip	0.00422	0.0139	CbGeAlD
Ruxolitinib—LTK—head—cleft lip	0.00408	0.0135	CbGeAlD
Ruxolitinib—RET—embryo—cleft lip	0.00407	0.0134	CbGeAlD
Ruxolitinib—CAMK1—head—cleft lip	0.00395	0.013	CbGeAlD
Ruxolitinib—CAMK2G—telencephalon—cleft lip	0.00389	0.0129	CbGeAlD
Ruxolitinib—LRRK2—telencephalon—cleft lip	0.00386	0.0127	CbGeAlD
Ruxolitinib—JAK2—embryo—cleft lip	0.00385	0.0127	CbGeAlD
Ruxolitinib—MARK2—head—cleft lip	0.00383	0.0127	CbGeAlD
Ruxolitinib—MAP3K2—telencephalon—cleft lip	0.00354	0.0117	CbGeAlD
Ruxolitinib—MAP3K7—telencephalon—cleft lip	0.0035	0.0116	CbGeAlD
Ruxolitinib—TYK2—telencephalon—cleft lip	0.00344	0.0114	CbGeAlD
Ruxolitinib—MKNK2—telencephalon—cleft lip	0.0034	0.0112	CbGeAlD
Ruxolitinib—IRAK1—telencephalon—cleft lip	0.0034	0.0112	CbGeAlD
Ruxolitinib—JAK3—head—cleft lip	0.00326	0.0108	CbGeAlD
Ruxolitinib—JAK1—head—cleft lip	0.00324	0.0107	CbGeAlD
Ruxolitinib—DCLK1—head—cleft lip	0.00324	0.0107	CbGeAlD
Ruxolitinib—CAMK1D—head—cleft lip	0.00316	0.0104	CbGeAlD
Ruxolitinib—PHKG2—head—cleft lip	0.00314	0.0104	CbGeAlD
Ruxolitinib—JAK2—telencephalon—cleft lip	0.00313	0.0103	CbGeAlD
Ruxolitinib—STK16—head—cleft lip	0.00304	0.01	CbGeAlD
Ruxolitinib—HIPK2—head—cleft lip	0.00302	0.00998	CbGeAlD
Ruxolitinib—MAP3K19—head—cleft lip	0.00296	0.00978	CbGeAlD
Ruxolitinib—DAPK3—head—cleft lip	0.00291	0.00959	CbGeAlD
Ruxolitinib—CLK2—head—cleft lip	0.00288	0.0095	CbGeAlD
Ruxolitinib—ROCK1—head—cleft lip	0.00279	0.00921	CbGeAlD
Ruxolitinib—TAOK3—telencephalon—cleft lip	0.00275	0.00908	CbGeAlD
Ruxolitinib—DYRK1A—head—cleft lip	0.00272	0.00898	CbGeAlD
Ruxolitinib—BMPR2—head—cleft lip	0.00271	0.00894	CbGeAlD
Ruxolitinib—CAMK2G—head—cleft lip	0.00243	0.008	CbGeAlD
Ruxolitinib—BMP2K—head—cleft lip	0.00243	0.008	CbGeAlD
Ruxolitinib—LRRK2—head—cleft lip	0.0024	0.00793	CbGeAlD
Ruxolitinib—MAP3K2—head—cleft lip	0.0022	0.00727	CbGeAlD
Ruxolitinib—TYK2—head—cleft lip	0.00214	0.00707	CbGeAlD
Ruxolitinib—MKNK2—head—cleft lip	0.00211	0.00698	CbGeAlD
Ruxolitinib—RET—head—cleft lip	0.00206	0.00681	CbGeAlD
Ruxolitinib—JAK2—head—cleft lip	0.00195	0.00643	CbGeAlD
Ruxolitinib—MAP3K3—head—cleft lip	0.00188	0.0062	CbGeAlD
Ruxolitinib—TAOK3—head—cleft lip	0.00171	0.00565	CbGeAlD
Ruxolitinib—JAK2—Signaling Pathways—NOG—cleft lip	8.85e-05	0.000127	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—FGF2—cleft lip	8.8e-05	0.000126	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—FGF9—cleft lip	8.74e-05	0.000125	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—NOS3—cleft lip	8.74e-05	0.000125	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—FGFR2—cleft lip	8.68e-05	0.000125	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—SPRY2—cleft lip	8.67e-05	0.000124	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—FGF7—cleft lip	8.67e-05	0.000124	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—FGF2—cleft lip	8.65e-05	0.000124	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—NOS3—cleft lip	8.61e-05	0.000124	CbGpPWpGaD
Ruxolitinib—CYP3A4—Biological oxidations—MTR—cleft lip	8.54e-05	0.000123	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—FGFR1—cleft lip	8.53e-05	0.000122	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—SPRY2—cleft lip	8.52e-05	0.000122	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—FGF7—cleft lip	8.52e-05	0.000122	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—NOS3—cleft lip	8.51e-05	0.000122	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—FGFR1—cleft lip	8.5e-05	0.000122	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—FGFR2—cleft lip	8.45e-05	0.000121	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—FGF8—cleft lip	8.43e-05	0.000121	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—FGFR2—cleft lip	8.42e-05	0.000121	CbGpPWpGaD
Ruxolitinib—PLK4—Cell Cycle, Mitotic—MYC—cleft lip	8.39e-05	0.00012	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—FGFR2—cleft lip	8.39e-05	0.00012	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—PTCH1—cleft lip	8.35e-05	0.00012	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—FGF10—cleft lip	8.28e-05	0.000119	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ABCA4—cleft lip	8.23e-05	0.000118	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—SUMO1—cleft lip	8.2e-05	0.000118	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—FGFR2—cleft lip	8.19e-05	0.000118	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—FGFR2—cleft lip	8.17e-05	0.000117	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—MTR—cleft lip	8.14e-05	0.000117	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—MTHFR—cleft lip	8.14e-05	0.000117	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—FGFR1—cleft lip	8.09e-05	0.000116	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—FGFR3—cleft lip	8.06e-05	0.000116	CbGpPWpGaD
Ruxolitinib—PLK1—Cell Cycle—MYC—cleft lip	8.05e-05	0.000115	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—FGFR3—cleft lip	8.03e-05	0.000115	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—FGF8—cleft lip	8e-05	0.000115	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—FGF10—cleft lip	7.96e-05	0.000114	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—FGFR1—cleft lip	7.88e-05	0.000113	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—FGF8—cleft lip	7.87e-05	0.000113	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—FGFR1—cleft lip	7.85e-05	0.000113	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—FGFR2—cleft lip	7.85e-05	0.000113	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—FGFR1—cleft lip	7.82e-05	0.000112	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—FGF2—cleft lip	7.77e-05	0.000111	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—FGFR2—cleft lip	7.73e-05	0.000111	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—FGF3—cleft lip	7.66e-05	0.00011	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—FGF10—cleft lip	7.65e-05	0.00011	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—FGFR3—cleft lip	7.64e-05	0.00011	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—FGFR1—cleft lip	7.63e-05	0.00011	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—FGF2—cleft lip	7.62e-05	0.000109	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—FGFR1—cleft lip	7.62e-05	0.000109	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—FGF3—cleft lip	7.57e-05	0.000109	CbGpPWpGaD
Ruxolitinib—PLK4—Cell Cycle—MYC—cleft lip	7.5e-05	0.000108	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—FGF7—cleft lip	7.5e-05	0.000108	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—FGF9—cleft lip	7.47e-05	0.000107	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—FGFR3—cleft lip	7.45e-05	0.000107	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—FGF3—cleft lip	7.43e-05	0.000107	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—FGFR3—cleft lip	7.42e-05	0.000106	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—FGFR3—cleft lip	7.39e-05	0.000106	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—FGF9—cleft lip	7.38e-05	0.000106	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—FGF10—cleft lip	7.38e-05	0.000106	CbGpPWpGaD
Ruxolitinib—HIPK2—Gene Expression—MYC—cleft lip	7.34e-05	0.000105	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—WNT3—cleft lip	7.33e-05	0.000105	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—NOS3—cleft lip	7.32e-05	0.000105	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—FGFR1—cleft lip	7.31e-05	0.000105	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—FGF2—cleft lip	7.3e-05	0.000105	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—FGF9—cleft lip	7.25e-05	0.000104	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—FGFR3—cleft lip	7.21e-05	0.000104	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—FGF3—cleft lip	7.21e-05	0.000103	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—FGFR1—cleft lip	7.2e-05	0.000103	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—NOS3—cleft lip	7.2e-05	0.000103	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—FGFR3—cleft lip	7.2e-05	0.000103	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—PTCH1—cleft lip	7.18e-05	0.000103	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—PTCH1—cleft lip	7.06e-05	0.000101	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—FGF9—cleft lip	7.03e-05	0.000101	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—FGF7—cleft lip	6.92e-05	9.94e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—SPRY2—cleft lip	6.92e-05	9.94e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—FGF8—cleft lip	6.92e-05	9.93e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—FGFR3—cleft lip	6.91e-05	9.92e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—FGF3—cleft lip	6.86e-05	9.85e-05	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—FGF2—cleft lip	6.86e-05	9.85e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—FGFR3—cleft lip	6.81e-05	9.76e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—PTCH1—cleft lip	6.8e-05	9.76e-05	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—NOS3—cleft lip	6.77e-05	9.71e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—FGFR1—cleft lip	6.74e-05	9.67e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—FGF9—cleft lip	6.69e-05	9.6e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—FGFR2—cleft lip	6.65e-05	9.54e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—SPRY2—cleft lip	6.59e-05	9.46e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—FGF7—cleft lip	6.59e-05	9.46e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—FGF3—cleft lip	6.51e-05	9.34e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—FGF2—cleft lip	6.49e-05	9.32e-05	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—MYC—cleft lip	6.41e-05	9.19e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—FGF3—cleft lip	6.4e-05	9.19e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—SPRY2—cleft lip	6.4e-05	9.18e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—FGF7—cleft lip	6.4e-05	9.18e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—FGF8—cleft lip	6.39e-05	9.17e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—FGFR2—cleft lip	6.38e-05	9.16e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—FGF9—cleft lip	6.35e-05	9.11e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—FGF10—cleft lip	6.3e-05	9.04e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—FGF9—cleft lip	6.24e-05	8.96e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—FGF2—cleft lip	6.23e-05	8.94e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—FGF10—cleft lip	6.22e-05	8.93e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—SPRY2—cleft lip	6.21e-05	8.9e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—FGF7—cleft lip	6.21e-05	8.9e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—FGF2—cleft lip	6.21e-05	8.9e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—FGFR1—cleft lip	6.19e-05	8.89e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—MTR—cleft lip	6.17e-05	8.86e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—FGFR2—cleft lip	6.14e-05	8.8e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—NOS3—cleft lip	6.12e-05	8.78e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—FGF10—cleft lip	6.11e-05	8.77e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—FGF8—cleft lip	6.08e-05	8.73e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—FGFR1—cleft lip	5.95e-05	8.54e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—FGF10—cleft lip	5.93e-05	8.51e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—FGFR2—cleft lip	5.92e-05	8.49e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—FGF2—cleft lip	5.91e-05	8.48e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—MTHFR—cleft lip	5.91e-05	8.48e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—FGF8—cleft lip	5.9e-05	8.47e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling by Wnt—MYC—cleft lip	5.87e-05	8.42e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—FGFR3—cleft lip	5.85e-05	8.4e-05	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—MYC—cleft lip	5.79e-05	8.31e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—FGF2—cleft lip	5.75e-05	8.26e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—FGF2—cleft lip	5.73e-05	8.23e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—FGF8—cleft lip	5.73e-05	8.22e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—FGFR1—cleft lip	5.72e-05	8.21e-05	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—FGF2—cleft lip	5.71e-05	8.19e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—NOS3—cleft lip	5.67e-05	8.14e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—FGF10—cleft lip	5.64e-05	8.1e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—FGF3—cleft lip	5.63e-05	8.08e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—FGFR3—cleft lip	5.62e-05	8.07e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—FGF2—cleft lip	5.58e-05	8e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—FGF2—cleft lip	5.56e-05	7.98e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—FGFR1—cleft lip	5.52e-05	7.92e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—FGF9—cleft lip	5.49e-05	7.88e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—PTCH1—cleft lip	5.46e-05	7.84e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—FGFR3—cleft lip	5.41e-05	7.76e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—FGF10—cleft lip	5.35e-05	7.68e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—FGF2—cleft lip	5.34e-05	7.66e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—PTCH1—cleft lip	5.3e-05	7.61e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—FGF10—cleft lip	5.27e-05	7.56e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—FGF2—cleft lip	5.26e-05	7.55e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—FGFR3—cleft lip	5.21e-05	7.48e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—FGF3—cleft lip	5.2e-05	7.46e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PTCH1—cleft lip	5.14e-05	7.38e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—FGF9—cleft lip	5.07e-05	7.28e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—FGFR2—cleft lip	5.05e-05	7.25e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—FGFR2—cleft lip	5e-05	7.17e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—FGF3—cleft lip	4.95e-05	7.1e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—FGF2—cleft lip	4.92e-05	7.06e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—FGFR2—cleft lip	4.91e-05	7.04e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—FGF7—cleft lip	4.85e-05	6.96e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—SPRY2—cleft lip	4.85e-05	6.96e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—FGF9—cleft lip	4.83e-05	6.93e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—FGF3—cleft lip	4.81e-05	6.9e-05	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—MYC—cleft lip	4.77e-05	6.85e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—NOS3—cleft lip	4.76e-05	6.83e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—FGFR2—cleft lip	4.76e-05	6.83e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—FGFR1—cleft lip	4.71e-05	6.76e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—FGF9—cleft lip	4.69e-05	6.72e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—FGF3—cleft lip	4.66e-05	6.69e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—FGFR1—cleft lip	4.66e-05	6.68e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—FGF10—cleft lip	4.63e-05	6.65e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—FGFR1—cleft lip	4.57e-05	6.56e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—FGF9—cleft lip	4.55e-05	6.52e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—FGFR2—cleft lip	4.53e-05	6.5e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—FGF2—cleft lip	4.52e-05	6.49e-05	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—MYC—cleft lip	4.49e-05	6.44e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—FGF8—cleft lip	4.48e-05	6.42e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—FGFR3—cleft lip	4.45e-05	6.39e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—FGFR1—cleft lip	4.44e-05	6.36e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—FGFR3—cleft lip	4.4e-05	6.31e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—MTHFR—cleft lip	4.36e-05	6.26e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—FGF2—cleft lip	4.35e-05	6.24e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—FGFR3—cleft lip	4.32e-05	6.2e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—FGFR2—cleft lip	4.3e-05	6.17e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—FGF10—cleft lip	4.28e-05	6.14e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—FGFR2—cleft lip	4.23e-05	6.06e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—FGFR1—cleft lip	4.22e-05	6.06e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—FGFR3—cleft lip	4.19e-05	6.01e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—FGF2—cleft lip	4.18e-05	5.99e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—NOS3—cleft lip	4.12e-05	5.91e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—FGF10—cleft lip	4.07e-05	5.84e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—MYC—cleft lip	4.06e-05	5.82e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—FGF2—cleft lip	4.03e-05	5.78e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PTCH1—cleft lip	4.02e-05	5.77e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—FGFR1—cleft lip	4.01e-05	5.75e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—FGFR3—cleft lip	3.99e-05	5.73e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—NOS3—cleft lip	3.97e-05	5.7e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—FGF10—cleft lip	3.95e-05	5.67e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—FGFR1—cleft lip	3.94e-05	5.65e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—FGF10—cleft lip	3.83e-05	5.5e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—FGFR3—cleft lip	3.79e-05	5.43e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—MYC—cleft lip	3.76e-05	5.4e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—FGFR3—cleft lip	3.72e-05	5.34e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—FGFR2—cleft lip	3.72e-05	5.34e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—FGF3—cleft lip	3.64e-05	5.23e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—FGF9—cleft lip	3.55e-05	5.1e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—FGFR1—cleft lip	3.47e-05	4.97e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—FGF2—cleft lip	3.44e-05	4.94e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—FGFR2—cleft lip	3.43e-05	4.93e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—FGF2—cleft lip	3.4e-05	4.88e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—NOS3—cleft lip	3.35e-05	4.81e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—FGF2—cleft lip	3.34e-05	4.79e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—MTHFR—cleft lip	3.3e-05	4.74e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—FGFR3—cleft lip	3.28e-05	4.7e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—FGFR2—cleft lip	3.27e-05	4.69e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—FGF2—cleft lip	3.24e-05	4.65e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—FGFR1—cleft lip	3.2e-05	4.59e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—FGFR2—cleft lip	3.17e-05	4.55e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—FGF2—cleft lip	3.08e-05	4.42e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—FGFR2—cleft lip	3.08e-05	4.41e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—FGFR1—cleft lip	3.05e-05	4.37e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—NOS3—cleft lip	3.04e-05	4.36e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—FGFR3—cleft lip	3.02e-05	4.34e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—FGF10—cleft lip	3e-05	4.3e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—FGFR1—cleft lip	2.96e-05	4.24e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—FGF2—cleft lip	2.93e-05	4.2e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NOS3—cleft lip	2.88e-05	4.14e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—FGFR3—cleft lip	2.88e-05	4.13e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—FGF2—cleft lip	2.88e-05	4.13e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—FGFR1—cleft lip	2.87e-05	4.11e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NOS3—cleft lip	2.84e-05	4.07e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—FGFR3—cleft lip	2.79e-05	4.01e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—MYC—cleft lip	2.73e-05	3.92e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—FGFR3—cleft lip	2.71e-05	3.89e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—MYC—cleft lip	2.63e-05	3.78e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SLC19A1—cleft lip	2.54e-05	3.65e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—FGF2—cleft lip	2.53e-05	3.63e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—FGFR2—cleft lip	2.4e-05	3.45e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—FGF2—cleft lip	2.34e-05	3.35e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NOS3—cleft lip	2.3e-05	3.31e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—FGFR1—cleft lip	2.24e-05	3.22e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—FGF2—cleft lip	2.22e-05	3.19e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—MYC—cleft lip	2.22e-05	3.19e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NOS3—cleft lip	2.19e-05	3.15e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—FGF2—cleft lip	2.16e-05	3.1e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NOS3—cleft lip	2.13e-05	3.06e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—FGFR3—cleft lip	2.12e-05	3.04e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—TCN2—cleft lip	2.11e-05	3.02e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—FGF2—cleft lip	2.09e-05	3.01e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NOS3—cleft lip	2.07e-05	2.96e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—MYC—cleft lip	2.02e-05	2.89e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—MYC—cleft lip	1.91e-05	2.74e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—MYC—cleft lip	1.88e-05	2.7e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—FGF2—cleft lip	1.64e-05	2.35e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NOS3—cleft lip	1.61e-05	2.32e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—MYC—cleft lip	1.53e-05	2.19e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—MTR—cleft lip	1.46e-05	2.1e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MYC—cleft lip	1.45e-05	2.09e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MYC—cleft lip	1.41e-05	2.03e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MYC—cleft lip	1.37e-05	1.96e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MYC—cleft lip	1.07e-05	1.54e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—TYMS—cleft lip	8.95e-06	1.28e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—MTHFR—cleft lip	7.82e-06	1.12e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—NOS3—cleft lip	5.46e-06	7.83e-06	CbGpPWpGaD
